Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Announces Presentations at 2015 American Society for Bone and Mineral Research Annual Meeting, Including New Data on Strensiq™ (asfotase alfa) in Children with Hypophosphatasia (HPP) Treated for Five Years

[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that researchers will present new data on the long-term efficacy and tolerability of Strensiq™ in children with hypophosphatasia who were treated for up to five . . . → Read More: Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Announces Presentations at 2015 American Society for Bone and Mineral Research Annual Meeting, Including New Data on Strensiq™ (asfotase alfa) in Children with Hypophosphatasia (HPP) Treated for Five Years Similar Articles: Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) to Ring The Nasdaq Stock Market Closing Bell Market Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015 Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report First Quarter 2015 Results on Thursday, April 23, 2015